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OBJECTIVE — Albuminuriacanbecausedbyendothelialdysfunctionasaresultofischemic
nephropathy rather than classic diabetic nephropathy. We studied whether renal vascular resis-
tance (resistive index [RI]) of the main renal arteries could be associated with albuminuria and
further assessed the relationship between RI and aorta stiffness measured by brachial-ankle
pulse-wave velocity (baPWV).
RESEARCH DESIGN AND METHODS — We consecutively studied 150 patients with
type2diabetesandtheabsenceofclinicallyovertrenalarterystenosis.Renalfunctionexpressed
as the estimated glomerular ﬁltration rate (eGFR) was calculated using the modiﬁed formula of
modiﬁcation of diet in renal disease (MDRD). The RI [(peak systolic velocity – end-diastolic
velocity)/peak systolic velocity] was measured with duplex Doppler ultrasonography.
RESULTS — When the presence of albuminuria (uAlb) was deﬁned as urinary albumin-to-
creatinineratio(g/mg creatinine)30,meanRI[(leftRIrightRI)/2]wassigniﬁcantlyhigher
in uAlb, compared with that in patients without uAlb. RI had signiﬁcant associations with age
(r  0.398, P  0.0001), diastolic blood pressure (r  0.398, P  0.0001), eGFR (r 
0.373, P  0.0001), and baPWV (r  0.223, P  0.05), respectively. Multivariate logistic
regression analysis showed that increased RI when deﬁned as RI 0.72 (median) was signiﬁ-
cantly associated with age (P  0.01, 95%CI 1.02–1.19), diastolic blood pressure (P  0.01,
0.86–0.97), and uAlb (P  0.01, 1.53–15.46), respectively. Moreover, RI was an independent
risk factor for uAlb after adjustment of both diastolic blood pressure and eGFR.
CONCLUSIONS — Renal vascular resistance was associated with albuminuria and aorta
stiffness.IncreasedRImayimplythepresenceofanytypeofunderlyingrenaldamage,including
ischemic nephropathy.
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D
uplex Doppler ultrasonography
was used to assess intrarenal hemo-
dynamics. The resistive index (RI)
calculated from blood ﬂow velocities in
vessels reﬂects renovascular resistance
and is known to increase in various disor-
ders (1–5). Moreover, vasoactive agents,
such as angiotensin II or ACE inhibitors
(6), are known to affect RI. Regarding
mechanisms by which RI of intrarenal ar-
terioles increase, we previously reported
that arterio-arteriolosclerosis rather than
interstitial ﬁbrosis could play an impor-
tantrole(7).Inaddition,wereportedthat
therewasadirectrelationshipbetweenRI
and arteriolosclerosis in damaged kid-
neys,andRIatrenalbiopsymaybeuseful
as one of the prognostic markers for renal
outcome (7).
According to the annual report of the
JapanDialysisTreatmentSocietyin2006,
themostfrequentcauseofend-stagerenal
disease is diabetes (8). Although diabetic
nephropathy has been considered to be a
microvascular complication, histopatho-
logical examination of renal biopsies
showed not only typical diffuse or nodu-
lar lesions, but also arteriosclerotic glo-
merulosclerosis (9). It has been reported
that RI in patients with renal dysfunction
(chronicrenalfailure)secondarytotype2
diabetes were signiﬁcantly increased
compared to the patients with nondia-
betic chronic renal failure (10). Further-
more, regardless of the status of
microalbuminuria, which has been con-
sidered to be a risk factor for diabetic ne-
phropathy and progression of renal
insufﬁciency, glomerular ﬁltration rate
(GFR) was also reported to be correlated
with RI (11). Indeed, there are several re-
ports showing a correlation between RI
and renal function (7,11,12). It is there-
fore conceivable that nonalbuminuric re-
nal insufﬁciency (13) could be related to
other pathogenetic disorders, such as
ischemicnephropathy,ratherthanclassic
diabetic nephropathy. In this regard, it
should be borne in mind that macroangi-
opathy, not microangiopathy, is likely to
affect GFR because systemic atheroscle-
rotic vascular disease adversely affects re-
nal blood perfusion, resulting in a
decrease of GFR, even if clinically overt
renal artery stenosis is not evident. Ish-
imura et al. (12) have already reported
that RI values are signiﬁcantly correlated
with both femoral and carotid arterial in-
tima-media thickness (IMT) in type 2 di-
abeticpatientswithnephropathyandthat
intrarenal hemodynamics are affected by
decreased GFR, probably through ad-
vanced arteriosclerosis. Recently, Ohta et
al. (14) reported that increased RI of the
main renal arteries is signiﬁcantly corre-
lated with the severity of systemic athero-
sclerosis. Furthermore, the intrarenal
vascular resistance differs depending on
the underlying renal disease and appears
to increase to a greater extent in diabetic
nephropathy(14).However,therelation-
shipbetweenRIandalbuminuriaremains
unknown, despite albuminuria being a
strong predictor of cardiovascular events
caused by endothelial dysfunction (15).
Therefore, we assessed the relation-
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and albuminuria. Moreover, we studied
the severity of other macroangiopathy ev-
idenced by an increase in aorta stiffness
measured by brachial-ankle pulse-wave
velocity (baPWV), carotid IMT, and an-
kle-brachial pressure index (ABI) in asso-
ciation with RI.
RESEARCH DESIGN AND
METHODS—We consecutively stud-
ied 150 patients with type 2 diabetes at-
tending the diabetes clinics in our
hospital between March 2005 and June
2006.Thediagnosisofdiabeteswasbased
onaprevioushistoryofdiabetesorfulﬁll-
mentofWorldHealthOrganizationcrite-
ria (16). Patients with known renal
arterialstenosis,orthosewithmalignancy
orsystemicdisorders,wereexcluded.The
study protocol was approved by the Re-
search and Ethics Committee of the Sho-
nan Kamakura General Hospital, and
informed consent was obtained.
Bloodwasdrawninthemorningafter
an overnight fast of at least 12 h. Urinary
albumin concentration was measured by
enzyme-linked immunosorbent assay us-
ing fresh spot urine and was expressed as
milligrams creatinine of urine. Nor-
moalbuminuriawasdeﬁnedasurinaryal-
bumin-to-creatinine ratio 30 g/mg in
two or more urine samples and no more
than one value 30 g/mg. Microalbu-
minuria was deﬁned as urinary albumin-
to-creatinine ratio 30–299 g/mg.
Macroalbuminuria was deﬁned by albu-
min-to-creatinineratio300g/mg.The
presence of albuminuria (uAlb) was de-
ﬁnedasurinaryalbumin-to-creatininera-
tio (g/mg   Cr) 30. Renal function
expressedbytheestimatedglomerularﬁl-
tration rate (eGFR) was calculated using
the modiﬁed formula of modiﬁcation of
diet in renal disease (MDRD) (17):
eGFR(male)(ml/min per 1.73 m
2)
 0.741  175  Age
0.203
 Cr
1.154 [if female: eGFR(male)
 0.742]
Comorbidity was recorded and ischemic
heart disease was deﬁned as the presence
or any history of myocardial infarction,
unstable angina, percutaneous coronary
intervention, or coronary artery bypass
graft surgery. Cerebrovascular disease
wasdeﬁnedasthepresenceoranyhistory
of cerebral or cellebellar infarction or
bleeding or subarachnoidal hemorrhage.
Peripheral arterial disease was deﬁned as
the presence or any history of bypass sur-
geryorpercutaneousperipheralinterven-
tion or limb ischemia as evidenced by
symptoms of intermittent claudication,
resting pain, or gangrene.
Duplex Doppler ultrasonography
All measurements were made after an
overnight fast in a supine position and
during suspended respiration at the end
of inspiration. Images were obtained with
a duplex Doppler apparatus (Aloka SSD
2000;Aloka,Tokyo,Japan)witha5-MHz
convex array probe in both real-time/
color-coded Doppler and pulse Doppler
modes. The ultrasound probe was posi-
tioned gently on the ﬂank in oblique pro-
jection,andthekidneywasvisualizedasa
longitudinal image. A Doppler beam was
placed on the main tract of the renal ar-
teries. RI was calculated by the built-in
software as follows: RI  (peak systolic
velocity  end-diastolic velocity)/peak
systolic velocity.
The use of antihypertensive agents
wasnotsuspendedbeforetheresistivein-
dex measurement. Although the patients
were not speciﬁcally screened for the
presence of undiagnosed renal artery ste-
nosis, we nevertheless measured the size
of the nephrogram and blood ﬂow at the
hilum of each kidney. None of the pa-
tientswhowereincludedinthestudyhad
a hilar acceleration time 100 cm/s or
had evidence of kidney atrophy 8 cm.
TheaverageofrightRIandleftRIwiththe
difference between the two kidneys not
15% was used as a marker of renal ar-
tery resistance in each individual.
Measurements were performed by
well-trainedstaffunawareofanyinforma-
tion concerning the patients. Regarding
reproducibility of measurements, inter-
observer and intraobserver variances
were 4.0 and 5.1%, respectively (7).
Aorta stiffness expressed as baPWV,
ABI, and carotid IMT
Aortic stiffness can be assessed noninva-
sively by measurement of baPWV (18).
Recently,anewandsimpledevicetomea-
sure baPWV has been developed. The de-
vice measures baPWV using an
oscillometric method (19). In this study,
the baPWV was automatically calculated
with the use of a Colin Waveform Ana-
lyzer (form PWV/ABI; Colin, Komaki, Ja-
pan). The instrument records baPWV,
blood pressure, electrocardiogram, heart
sounds,andABIsimultaneously.Validity,
reproducibility, and clinical signiﬁcance
of noninvasive baPWV measurement
have been reported elsewhere (19). ABI
was estimated by ankle systolic blood
pressure/brachial systolic blood pressure.
According to our previous report
(20), both carotid arteries were examined
using a 7.5-MHz linear array transducer
with high-resolution B-mode ultrasonog-
raphy (Aloka, Tokyo, Japan). The IMT
was deﬁned as the distance between the
leading edge of the lumen-intima echo of
the near wall and the leading edge of the
media-adventitia echo. The maximum
IMT was recorded in the right and left
carotid arteries, respectively. In addition
to RI, baPWV, IMT, and ABI were ex-
pressed as an average of right and left
measurements, respectively.
Statistical analysis
AllthedataareexpressedasmeansSD.
Differences between the two groups were
analyzed by an unpaired Student’s t test.
One-way ANOVA was used for multiple
comparisons of more than three groups
followed by Scheffe’s test. Logistic multi-
ple regression analysis was performed to
determine more related variables for RI.
Increased RI when deﬁned as RI 0.72
(median) was used for logistic regression
analysis. The F value for a candidate’s en-
trance or removal from the discriminate
function test was set at 4.0. The level of
statistical signiﬁcance was deﬁned as P 
0.05. All the statistical analysis was per-
formedwithSAS/Windows(Statviewver-
sion 5.0).
RESULTS—Basic characteristics of the
150 patients are shown in Table 1. Mean
ageSDwas66.110.2years,andA1C
was 8.01  1.81%. Serum creatinine and
eGFRwere0.940.43mg/dland77.6
22.0 ml/min per 1.73 m
2, respectively.
Systolic blood pressure (sBP) and dia-
stolic blood pressure (dBP) were both rel-
atively well controlled (sBP 139  21
mmHg and dBP 79  14 mmHg). Co-
morbidityandco-currentuseofdrugsare
also shown in Table 1. The median of uri-
nary albumin excretion was 22.8 g/mg  
Cr. The RI of all patients was 0.720 
0.071. The baPWV, IMT, and ABI values
were 1,894  519 cm/s, 0.943  0.123
mm,and1.110.12,respectively(Table
1).
RI was signiﬁcantly higher in patients
withmacroalbuminuria(0.7450.077),
compared with that in patients with nor-
moalbuminuria (0.707  0.067) (P 
0.01), as shown in Fig. 1. Univariate re-
gression analysis showed that RI had sig-
Albuminuria and macroangiopathy in type 2 diabetes
1854 DIABETES CARE, VOLUME 31, NUMBER 9, SEPTEMBER 2008niﬁcant associations with age (r  0.398,
P  0.0001), dBP (r  0.398, P 
0.0001), eGFR (r  0.373, P 
0.0001), and baPWV (r  0.223, P 
0.05) (Table 2), respectively. Urinary al-
bumin excretion, as a continuous vari-
able, was not correlated with RI.
Multivariate logistic regression analysis
showedthatindependentofeGFR,RIwas
signiﬁcantly associated with age (P 
0.01, 95% CI 1.02–1.18), dBP (P  0.01,
0.86–0.97), and uAlb (when the pres-
ence of albuminuria was deﬁned as uri-
naryalbumin-to-creatinineratio30g/
mg:uAlb) (P  0.01, 1.53–15.46) (Table
3), respectively. However, baPWV, IMT,
and ABI as well as eGFR were not identi-
ﬁed as independent risk factors for in-
creased RI. Also, when uAlb was
considered as a dependent variable, RI
(P  0.05) as well as dBP (P  0.05) and
eGFR (P  0.01) remained signiﬁcant as
independent risk factors.
CONCLUSIONS—In the present
study, we showed that renal vascular re-
sistance was higher in patients with mac-
roalbuminuria. After an adjustment of
eGFR, RI remained signiﬁcant and was an
independent risk factor for the presence
of albuminuria. Therefore, RI is a useful
marker for the presence of any type of
nephropathy found in type 2 diabetes.
When we consider the stages of diabetic
nephropathy, it is plausible that there is a
stage in which albuminuria and GFR do
not always correspond to each other. Re-
cent results regarding the pathophysiol-
ogy of renal disease in type 2 diabetes
havechallengedtheconceptthatadecline
in renal function in patients with diabetes
is always accompanied by increased albu-
minuria.MacIsaacetal.(11)havesuggested
that renal insufﬁciency, without albumin-
uria, is common in type 2 diabetes.
Increased RI is known to be corre-
lated with renal dysfunction or urinary
albumin excretion in hypertensive pa-
tients under treatment with ACE inhibi-
tors (6). We showed that RI was
correlated with macroalbuminuria. Re-
cently, Nosadini et al. (21) showed that
increasedrenalarterialresistancepredicts
the course of renal function in type 2 di-
abetes with microalbuminuria. The pa-
tients with RI 0.8 showed a signiﬁcant
deterioration in GFR. However, albumin
excretion rate was similar in both the pa-
tients with RI above or below 0.8 at base-
line, although overt proteinuria tended to
develop more frequently in patients with
RI 0.8. Therefore, the present study
mayindicatethatRIwassigniﬁcantlycor-
related with albuminuria except in nor-
moalbuminuric patients. Considering the
ﬁnding that RI was not correlated with
proteinuria in patients with idiopathic
chronic glomerulonephritis (7), the re-
sultsofthepresentstudymayalsosuggest
the difference in the pathophysiological
signiﬁcance of albuminuria between both
groups: those with chronic glomerulone-
phritis and those with diabetes. In dia-
betic patients, polyvascular disease based
Figure1—RIwassigniﬁcantlyhigherinpatientswithmacroalbuminuria(DN)(0.7450.077)
compared with that in patients with normoalbuminuria (NA) (0.707  0.067) (P  0.01). MA,
microalbuminuria.
Table 1—Basic characteristics of the patients
n 150
Sex (M/F) 102/48
Age (years) 66.1  10.2
A1C (%) 8.01  1.81
sBP (mmHg) 139  21
dBP (mmHg) 79  14
Total cholesterol (mg/dl) 207  40
Triglycerids (mg/dl) 170  176
HDL (mg/dl) 54  17
Creatine (mg/dl) 0.94  0.43
eGFR (ml/min per 1.73 m
2) 77.6  22.0
RI 0.720  0.006
baPWV (cm/s) 1,894  510
IMT (mm) 0.94  0.23
Urinary albumin excretion (g/mg   creatinine) 215.1  640
Comorbidity
Hypertension (%) 72.0
Hyperlipidemia (%) 64.0
Ischemic heart disease (%) 35.3
Cardiovascular disease (%) 8.7
Peripheral arterial disease (%) 12.7
Drugs
Angiotensin receptor blockade (%) 50.7
ACE inhibitors (%) 14.0
Calcium-channel blockers (%) 38.7
Data are means  SD.
Table 2—Univariate regression analysis as-
sociated with RI
RP
Age 0.398 0.0001
sBP 0.136 0.126
dBP 0.398 0.0001
A1C 0.064 0.460
Urinary albumin
excretion
0.0616 0.882
eGFR 0.373 000.1
baPWV 0.223 0.015
IMT 0.142 0.154
ABI 0.167 0.065
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could affect renal injury through long-
term intrarenal ischemia. Indeed, in-
creased urinary albumin excretion can be
a marker of coexisting coronary artery
diseaseinpatientswithperipheralarterial
disease (22). Atherosclerosis affects dif-
ferent vascular systems resulting in poly-
vascular disease. Recently, the REACH
(Reduction of Atherothrombosis for Con-
tinued Health) study revealed that coro-
nary, cerebral, and peripheral arterial
diseases are superimposed on one an-
other (23). In the patients with diabetes,
endothelial cells of the renal or intrarenal
artery, in addition to glomeruli, would be
more affected by atherosclerosis than
thoseinthepatientswithchronicglomer-
ulonephritis. On the other hand, albu-
minuria in the patients with chronic
glomerulonephritis may be more likely
derived from glomerular capillary dam-
agealonewithout(orwithless)damageto
the main renal artery. This may be the
reason why RI was not correlated with
proteinuria in the patients with chronic
glomerulonephritis.
Renal injury in diabetic patients in-
cludes various pathophysiological disor-
ders. In this regard, we need to be aware
of ischemic nephropathy resulting from
diminished renal blood perfusion, even if
clinically overt renal artery stenosis is ab-
sent. Ischemic nephropathy originally re-
ferstothereductionofGFRthatiscaused
by hemodynamically signiﬁcant renal ar-
teryobstruction(24).However,themajor
clinical questions confronting the neph-
rologist in considering the diagnosis of
ischemic nephropathy include, “Which
clinical or laboratory features are most
useful in its detection?” The ﬁnding that
increased RI of renal arteries is signiﬁ-
cantlycorrelatedwithalbuminuriawould
provide a clue to study the clinical prog-
nosis of less severe but long-term isch-
emic nephropathy. Endothelial cells in
glomerular capillary could be easily in-
juredbymechanicalstressincludingisch-
emia. It has been recently reported that
even in proteinuric subjects without dia-
betes, there is evidence of macrovascular
endothelial dysfunction remote from the
kidney and of low-grade inﬂammation
that is associated with microvascular en-
dothelial dysfunction (25).
In conclusion, increased RI may im-
plythepresenceofanytypeofunderlying
renal damage, including ischemic ne-
phropathy resulting in endothelial dys-
function in type 2 diabetes.
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